John Poss: May 23, 2018

How to Unleash the Medical Magic of the Cannabis Plant

Federal Support of CBD Research Could Be Catalyst for the Medical Marijuana Industry 

John Poss

Chairman and CEO of GB Sciences, Inc.

 

 

The legal cannabis industry continues to be one of the fastest growing areas of North America’s economy. The legalization of medical cannabis in Canada and many American states has fostered a thriving medical cannabis industry over the past decade, consisting of everything from pharmaceutical companies to retail specialists. With recreational use now legal in several states, the industry is set to blossom further.

On April 13th President Donald Trump announced unprecedented support of legalizing marijuana. This is a very big step for companies that are researching CBDs (cannabidiols) found in marijuana and other products for consumers, and patients. CBD is a natural substance obtained from hemp plants that can promote wellness without any psychoactive or intoxicating effectsChuck Schumerand the democrats also recently introduced legislation to decriminalize marijuana on the federal level. This is extremely important in helping company’s research marijuana and, more importantly, cannabinoids. These moves by democrats, and the President, could be a massive catalyst for companies involved in the industry.

Did you know?

  • The legal cannabis market was worth $6.6 billion in 2016 and is forecast to grow to $24.1 billion by 2025 with compound annual growth rate of 16 percent.
  • By segment, the medical cannabis market was worth $4.7 billion in 2016 and is expected to grow to $13.3 billion by 2025.
  • Sales of recreational cannabis during the same time period are expected to grow at a 21 percent CAGR, from $1.9 billion to $10.9 billion

On Wed May 23rd, GB Sciences CEO and former cancer patient John Poss is available to you and your listeners to explain how to unleash the medical magic of the Cannabis plant, give insight on where the legalized marijuana market is heading and provide solutions to managing the discord between Federal and State policy.

 

For more information please visit www.gbsciences.com 

 

MORE ABOUT JOHN POSS:

Mr. Poss has over 30 years of experience working as a consultant to companies facing major transitions and transformations. He began his career in the Washington, D.C. office of Arthur Andersen & Co. and has served as Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Technology Officer of both public and private companies in such diverse industries as homebuilding, mining, telecommunications, manufacturing, logistics, construction lending and mortgage banking.

Trackbacks

  1. […] Commentator Bill Martinez interviews GB Sciences CEO John Poss – May 23, 2018 […]

Speak Your Mind

*